BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, May 11, 2026
Home » Topics » Medical technology, Science

Medical technology, Science
Medical technology, Science RSS Feed RSS

BioWorld MedTech’s Neurology Extra for Dec. 4, 2020

Dec. 4, 2020
By Andrea Applegate
Keeping you up to date on recent developments in neurology, including: AI developed to predict psychiatric diagnoses from Facebook activity; AIR coil from GE Healthcare shows promise for whole-brain imaging; Big data analysis suggests role of brain connectivity in epilepsy-related atrophy; Gestational age linked to ADHD in children with Down syndrome.
Read More
Heart, implant illustration

Researchers are working on a new implant for minimally invasive mitral valve repair

Dec. 3, 2020
By Bernard Banga
PARIS – Researchers at the Biomechanics and Bioengineering laboratory (BMBI), a joint venture between the Compiègne University of Technology in Oise, France, and the National Center for Scientific Research (CNRS), have designed a new implant intended for minimally invasive surgery for mitral valve repair. One of the BMBI teams has been working closely two cardiovascular surgeons from the University Hospital of Henri-Mondor to develop this new minimally invasive approach in the treatment of mitral valve regurgitation.
Read More

BioWorld MedTech’s Diagnostics Extra for Dec. 3, 2020

Dec. 3, 2020
By Meg Bryant and Anette Breindl
Keeping you up to date on recent developments in diagnostics, including: Quantum nanodiamonds could improve disease detection; Field-friendly approach could aid in malaria control; Equine encephalitis’ entry elucidated.
Read More

Bluestar Genomics, University of Chicago see publication of 5hmC map

Dec. 2, 2020
By Liz Hollis
Bluestar Genomics Inc. and the University of Chicago revealed the publication of a genome-wide 5-hydroxymethylcytosine (5hmC) map across multiple human tissue types. In the report, published Dec. 2, 2020, in Nature Communications, the researchers detailed the development of the map by characterizing the genomic distributions of 5hmC in 19 human tissues derived from 10 organ systems.
Read More

BioWorld MedTech’s Orthopedics Extra for Dec. 2, 2020

Dec. 2, 2020
By Holland Johnson
Keeping you up to date on recent developments in orthopedics, including: Researchers develop new biomaterial that helps bones heal faster; Obesity increases the risk of early hip fracture in postmenopausal women; Vitamin D regulates calcium in intestine differently than previously thought.
Read More

BioWorld MedTech’s Oncology Extra for Dec. 1, 2020

Dec. 1, 2020
By Mark McCarty and Anette Breindl
Keeping you up to date on recent developments in oncology, including: New assay may aid in the use of proteases as diagnostic for a range of cancers; New vulnerability in ‘KL’ KRAS subtype; Ferropoptosis gains new credibility as cancer treatment.
Read More

BioWorld MedTech’s Cardiology Extra for Nov. 30, 2020

Nov. 30, 2020
By Liz Hollis
Keeping you up to date on recent developments in cardiology, including: Remote help to lower BP, control cholesterol; Improving screening for dual heart disease; Candidate shows promise in reducing heart failure.
Read More
Ribbons of digital data

‘We will understand how humans work’ with Deepmind’s new algorithm

Nov. 30, 2020
By Nuala Moran
LONDON – The Google artificial intelligence company Deepmind has developed an algorithm that can predict the 3D structure of a protein from its amino acid sequence, making it possible to solve the structures of proteins, such as G-protein coupled receptors (GPCRs), which are a mainstay of drug targeting but whose structure is challenging to determine with current methods.
Read More

BioWorld MedTech’s Orthopedics Extra for Nov. 25, 2020

Nov. 25, 2020
By Holland Johnson
Keeping you up to date on recent developments in orthopedics, including: Potential cellular target for eliminating bone breakdown in osteoporosis found; Popular weight-loss surgery in teenagers weakens bones; Study: Early, late stages of degenerative diseases are distinct.
Read More

BioWorld MedTech’s Oncology Extra for Nov. 24, 2020

Nov. 24, 2020
By Mark McCarty and Anette Breindl
Keeping you up to date on recent developments in oncology, including: Nanoparticles may blunt TRIM37’s impact on metastasis in triple-negative breast cancer; Glycolysis inhibition via collateral lethality; Making exceptional responders unexceptional; Protons may spare cancer patients a hit to the heart.
Read More
Previous 1 2 … 28 29 30 31 32 33 34 35 36 … 69 70 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 11, 2026.
  • Rendering of a key measles protein targeted by neutralizing human antibodies

    First measles treatment advances as vaccination rates drop

    BioWorld
    Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
  • Infensa Bioscience identifies new ASIC blockers

    BioWorld Science
    Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
  • Close up of bow of cruise ship

    Hantavirus is ‘sentinel’ more than acute pandemic threat

    BioWorld
    News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
  • Neurology illustration

    Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst

    BioWorld
    Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing